Search Results
Optimizing treatment in patients with early-stage HER2-positive breast cancer
Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and Toxicity
Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo
Optimizing Therapy in HER2+ Disease with Dr. Reshma Mahtani
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg
Optimizing adjuvant treatment in HR+/HER2- early breast cancer
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. Vogel
HER2+ Early-Stage Breast Cancer: Neoadjuvant Strategies
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’Regan
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Traina & Dr. Carey
Optimizing Treatment Options for HER2+/ ER+ Breast Cancer using Models of Endocrine Resistance
Dr. Meisel on Optimizing Genomic Assays in Early-Stage HR-Positive, HER2-Negative Breast Cancer
